Expert consensus on quality control indicators of integrative medicine in primary Sjögren's syndrome (2023 version)

Abstract

Treatment integrating traditional Chinese and Western medicine for primary Sjögren's syndrome (pSS) has yielded positive results and gained wide acceptance. However, the absence of standardized clinical management in certain regions has led to suboptimal outcomes in the diagnosis and treatment of pSS in China. In response, the Center for Traditional Chinese and Western Medicine at the China-Japan Friendship Hospital, in collaboration with the Beijing Association of Traditional Chinese and Western Medicine Rheumatology Professional Committee, initiated a project led by the Traditional Chinese Medicine Department of Rheumatism. The project (Beijing Association of the Integrating of Traditional and Western Medicine standardization expert consensus record number: 2021Z031A3) aims to develop a set of quality control indicators for the integrated treatment of pSS using traditional Chinese and Western medicine. Based on the 2021 version, the consensus revision incorporates seven new items, focusing on essential assessment areas for pSS patients, treatment response, and healthcare cost management. The 2023 expert consensus update seeks to enhance pSS diagnosis and treatment practices in China, offering a benchmark for medical quality control.

References

[1] Zhang W , Li XM , Xu D , et al. Recommendations of diagnosis and treatment of primary Sjögren’s syndrome in China. Chin J Intern Med. 2020; 59 (4): 269- 276 (in Chinese).

[2] Chinese Rheumatology Association . Guideline on diagnosis and treatment of primary Sjögren’s syndrome. Chin J Rheum. 2010; 14 (11): 766- 768 (in Chinese).

[3] Li ZG , Zhang FC , Zeng XF . Rheumatology. People’s Military Medical Press; 2014: 108- 117 (in Chinese).

[4] Tao QW , Luo J , Wang JM , et al. Expert consensus on quality control indicators of integrative medicine in primary Sjögren’s syndrome (2021 version). J China-Jpn Friendsh Hosp. 2021; 35 (02): 70- 72 (in Chinese).

[5] Seror R , Bootsma H , Saraux A , et al. EULAR Sjögren’s Task Force. Defining disease activity states and clinically meaningful improvement in primary Sjögren’s syndrome with EULAR primary Sjögren’s Syndrome Disease Activity (ESSDAI) and Patient-Reported Indexes (ESSPRI). Ann Rheum Dis. 2016; 75 (2): 382- 389.

[6] Hackett KL , Gotts ZM , Ellis J , et al. An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature. Rheumatology. 2017; 56 (4): 570- 580.

[7] Omachi TA . Measures of sleep in rheumatologic diseases: Epworth sleepiness scale (ESS), functional outcome of sleep questionnaire (FOSQ), insomnia severity index (ISI), and Pittsburgh sleep quality index (PSQI). Arthritis Care Res. 2011; 63 (Suppl 11): S287- S296.

[8] Barendregt PJ , Visser MR , Smets EM , Tulen JH , van den Meiracker AH , Boomsma F , Markusse HM . Fatigue in primary Sjögren’s syndrome. Ann Rheum Dis. 1998; 57 (5): 291- 295.

[9] Cui Y , Xia L , Li L , Zhao Q , Chen S , Gu Z . Anxiety and depression in primary Sjögren’s syndrome: a cross-sectional study. BMC Psychiatr. 2018; 18 (1): 131.

[10] Anyfanti P , Pyrpasopoulou A , Triantafyllou A , et al. Association between mental health disorders and sexual dysfunction in patients suffering from rheumatic diseases. J Sex Med. 2014; 11 (11): 2653- 2660.

[11] Seror R , Baron G , Camus M , et al. Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome. Ann Rheum Dis. 2022; 81: 979- 989.

[12] Arends S , de Wolff L , van Nimwegen JF , et al. Composite of Relevant Endpoints for Sjögren’s Syndrome (CRESS): development and validation of a novel outcome measure. Lancet Rheumatol. 2021; 3 (8): e553- e562.

[13] Dong Y . The necessity and importance of standardized diagnosis and treatment of primary Sjögren’s syndrome. Chin J Intern Med. 2020; 59 (4): 267- 268 (in Chinese).

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Advanced Chinese Medicine published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.